Trial ID or NCT#

NCT03179449

Status

RECRUITING

Purpose

This pilot early phase I trial studies how well ferumoxytol-enhanced magnetic resonance imaging (MRI) correlates with inflammatory (macrophage) responses in pediatric patients with malignant brain tumors. If there is good correlation, ferumoxytol-enhanced MRI can serve as a noninvasive imaging biomarker of inflammation.

Official Title

MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI (Pediatric Brain Tumor Protocol)

Eligibility Criteria

Ages Eligible for Study: Older than 2 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Michael Iv
Radiologist
Clinical Associate Professor, Radiology
Gerald Grant, MD, FACS
Pediatric neurosurgeon
Endowed Professor in Pediatric Neurosurgery and Professor, by courtesy, of Neurology at the Stanford University Medical Center
Kristen Yeom
Associate Professor of Radiology and, by courtesy, of Neurosurgery at the Lucile Salter Packard Children's Hospital and the Stanford University Medical Center
Michael S. B. Edwards, MD

Contact us to find out if this trial is right for you.

CONTACT

Paymon Rezaii
(650) 743-8336